Holen Sie sich die Stockscreener-App
126.65
0.80%
1.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$125.64
Offen:
$126.665
24-Stunden-Volumen:
4.50M
Relative Volume:
0.87
Marktkapitalisierung:
$55.81B
Einnahmen:
$9.40B
Nettoeinkommen (Verlust:
$2.65B
KGV:
21.34
EPS:
5.935
Netto-Cashflow:
$2.24B
1W Leistung:
-0.60%
1M Leistung:
+1.63%
6M Leistung:
-16.92%
1J Leistung:
-23.21%
1-Tages-Spanne:
$125.65
$130.65
1-Wochen-Bereich:
$118.94
$132.49
52-Wochen-Spanne:
$115.25
$177.00
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Lyell Wealth Management LP Sells 19,845 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Global Q4 and Full-Year 2025 Earnings: Revenue Beats $2.4B - Bayelsa Watch
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook - Finviz
Zoetis Inc (NYSE:ZTS) Provides Optimistic FY26 Outlook - FXDailyReport.Com
Zoetis Inc. (NYSE:ZTS) Q4 2025 Earnings Call Transcript - Insider Monkey
Leerink Partners Adjusts Price Target on Zoetis to $133 From $130, Maintains Market Perform Rating - marketscreener.com
Zoetis (ZTS) Receives Updated Price Target from B of A Securitie - GuruFocus
Bank of America Forecasts Strong Price Appreciation for Zoetis (NYSE:ZTS) Stock - MarketBeat
Assessing Zoetis: Insights From 5 Financial Analysts - Benzinga
Wealthfront Advisers LLC Purchases 13,097 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Q4 Earnings Call Highlights - Yahoo Finance
ING Groep NV Takes $4.58 Million Position in Zoetis Inc. $ZTS - MarketBeat
Will Zoetis Inc. outperform the market in YEARInsider Buying & Accurate Intraday Trading Signals - mfd.ru
Atria Investments Inc Trims Holdings in Zoetis Inc. $ZTS - MarketBeat
Jim Cramer on Zoetis (ZTS): “It Does Seem to Be Dead Money” - MSN
Decoding Zoetis Inc (ZTS): A Strategic SWOT Insight - GuruFocus
Zoetis Delivers Strong Q4 2025 Beat; Sets Sights on Long-Acting Growth in 2026 - AlphaStreet News
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Y - GuruFocus
Zoetis Inc. SEC 10-K Report - TradingView
Zoetis Stock Is In The Doghouse Despite Its Quarterly Beat; Here's Why - Investor's Business Daily
Zoetis (ZTS) Projects Strong FY26 Revenue and Net Income Growth - GuruFocus
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Year Growth Amid Competitive ... - Yahoo Finance
Zoetis (ZTS) Surpasses Revenue Expectations in Q4, Highlights Fu - GuruFocus
Zoetis forecasts strong 2026 profit, revenue on steady pet-medicine demand - marketscreener.com
Zoetis Q4 2025 Earnings Beat Expectations - Intellectia AI
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide - Benzinga
Zoetis (ZTS) Q4 2025 Earnings: Strong International Growth and S - GuruFocus
How Investors May Respond To Zoetis (ZTS) Strong 2025 Results And Confident 2026 Earnings Guidance - Yahoo Finance
Zoetis (ZTS) Shares Dip Despite Beating Q4 2025 Expectations - GuruFocus
Zoetis (ZTS) Exceeds Q4 Expectations with Strong Earnings - GuruFocus
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates - Finviz
Zoetis forecasts upbeat 2026; pet‑care market pressure drags shares - TradingView
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 By Investing.com - Investing.com India
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 By Investing.com - Investing.com Nigeria
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 - Investing.com
Zoetis slips as outlook shows growth headwinds (ZTS:NYSE) - Seeking Alpha
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market - FinancialContent
Earnings call transcript: Zoetis beats Q4 2025 EPS forecast, stock dips - Investing.com
Fund Update: 113,803 ZOETIS (ZTS) shares added to South Dakota Investment Council portfolio - Quiver Quantitative
Jefferies reiterates Buy rating on Zoetis stock with $170 price target By Investing.com - Investing.com India
Jefferies reiterates Buy rating on Zoetis stock with $170 price target - Investing.com Nigeria
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 - Investing.com
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance Singapore
Sector Update: Health Care - marketscreener.com
Zoetis (NYSE:ZTS) Updates FY 2026 Earnings Guidance - MarketBeat
Zoetis (ZTS) Q4 2025 Earnings Call Transcript - The Globe and Mail
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates - The Globe and Mail
Zoetis Inc. (NYSE:ZTS) Reports Q4 Earnings Beat and Steady 2026 Guidance - ChartMill
Zoetis Inc. Provides Earning Guidance for the Full Year 2026 - marketscreener.com
Zoetis stock rises after strong Q4 earnings and upbeat 2026 outlook - Investing.com Canada
Zoetis's (NYSE:ZTS) Q4 CY2025 Sales Top Estimates - Finviz
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):